ESR1 and breast cancer: In terms of breast cancer pathogenesis, the risk of breast cancer development associated with weight gain, a surrogate for increasing subclinical inflammation, has been shown to be higher for ER+/PR+ breast cancer than for ER−/PR− breast cancer27.